Roth Capital Downgrades CardioNet (BEAT) to Hold
BEAT Hot Sheet
Rating Summary:0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 7 | New: 18
Roth Capital downgrades CardioNet (Nasdaq: BEAT) from Buy to Hold. Price target slashed from $29 to $18.
To see more analyst ratings on BEAT Click Here.
CardioNet, Inc. provides ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health in the United States.
To see more analyst ratings on BEAT Click Here.
CardioNet, Inc. provides ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health in the United States.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Barclays Maintains an 'Equalweight' on Trina Solar (TSL); Waiting on Growth in Gross Margins and Stabilized Opex
- Nomura Securities Maintains a 'Neutral' on Tiffany & Co. (TIF); Cutting Estimates and Price Target
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
